A woman who claimed in a lawsuit that GSK’s discontinued heartburn drug Zantac caused her breast cancer dropped her case ...
A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case ...
GSK and other drugmakers on Monday asked a Delaware court for permission to appeal a ruling allowing more than 70,000 ...
A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that ...
As the year rolls on, GSK continues to knock out personal injury lawsuits in the long-running legal saga over whether the ...
The resulting influx of cases could have significant consequences for the efficient administration of justice in Delaware, ...
As Dame Emma Walmsley stood up to deliver GSK’s latest set of results last month, she was brimming with confidence. This was ...
The companies, which all sold Zantac at different times, argue that Medinilla should have granted their motion to block ...
Shore Capital analysts estimated that up to $30bn (£24bn) for litigation was already priced into GSK’s shares.
Seamless reading experience. Save your favourite. Amgen is appealing a lower court's ruling that invalidated two of its patents on Repatha, a drug that can reduce risk of heart attack and stroke in ...
Some claims on social media about sun safety have grown into a major misconception that sunscreen could cause skin cancer. Hundreds of creators, many on TikTok, have posted videos arguing that the ...